BDSX

Biodesix, Inc. (BDSX) ESG Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-08-01

Environmental

BDSX’s R&D intensity supports diagnostic innovation, but peers with larger scale typically convert similar spending into broader sustainability and compliance capabilities more efficiently.

The company’s asset-light profile likely limits direct environmental footprint versus laboratory-heavy peers, yet the available metrics do not evidence a clear emissions or resource-use advantage.

No disclosed environmental metrics in the provided data indicate superior waste, energy, or climate management relative to peers, keeping the environmental profile mid-pack.

Because the business appears more exposed to product and regulatory quality than physical environmental externalities, environmental risk is material but not a primary peer differentiator.

Social

BDSX’s high gross margin and meaningful R&D spend suggest a science-led model that can support patient value, but peers often show stronger scale in access and adoption.

The provided metrics show moderate stock-based compensation, which can aid talent retention, although peer-leading life-science firms often pair this with deeper workforce disclosure and engagement.

As a diagnostics company, social performance depends heavily on test quality and clinical trust, yet no provided data demonstrate a peer-leading record on these factors.

Without evidence of broader access, diversity, or safety disclosures, BDSX appears broadly aligned with peers but not clearly advantaged on social execution.

Governance

BDSX’s debt-to-equity ratio is very high versus typical peers, which can constrain governance flexibility and heighten oversight concerns around capital discipline.

Negative net debt to EBITDA suggests some balance-sheet support, but the leverage profile still looks structurally weaker than better-capitalized diagnostics peers.

Stock-based compensation at roughly 4% of revenue is manageable, yet it still dilutes alignment quality relative to peers with tighter compensation discipline.

The absence of provided disclosure on board independence, audit controls, or controversy management limits confidence, leaving governance below stronger peer standards.

Overall Score

BDSX’s ESG positioning is mixed, with a relatively constructive social profile offset by weaker governance leverage and only average environmental differentiation versus peers.

Score Driver: High Leverage And Limited Governance Disclosure Are The Main Relative ESG Constraints.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Biodesix, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →